Cancer after pre-eclampsia: Follow up of the Jerusalem perinatal study cohort

British Medical Journal

Volumn 328, Issue 7445, 2004, Pages 919-921

  Paltiel, Ora ^a   Friedlander, Yehiel ^a   Tiram, Efrat ^a   Barchana, Micha ^b   Xue, Xiaonan ^c   Harlap, Susan ^d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; EPITHELIUM; FEMALE; FOLLOW UP; HOSPITAL; HUMAN; ISRAEL; KIDNEY CANCER; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PERINATAL PERIOD; PREECLAMPSIA; PRIORITY JOURNAL; STOMACH CANCER;

EID: 1942510619     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38032.820451.7c     Document Type: Article

References (17)

1. Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology 1999;10:722-32.
2. Peleg L, Pesso R, Goldman B, Dotan K, Omer M, Friedman E, et al. Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel. Isr Med Assoc J 2002;4:95-7.
3. Davies AM, Prywes R, Tzur B, Wesikopf P, Sterk VV. The Jerusalem Perinatal Study. 1. Design and organization of a continuing, community-based, record linked survey. Isr J Med Sci 1969;5:1095-1106.
4. Israel Center for Disease Control. Investigation into the completeness of the Israel Cancer Registry. Methods and results. Publication 230. Israel Center for Disease Control, Oct 2003:31. (In Hebrew.)
5. Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R. Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 2002;87:971-3.
6. Polednak AP, Janerich DT. Characteristics of first pregnancy in relation to early breast cancer. A case-control study. J Reprod Med 1983;28:314-8.
7. Thompson W, Jacobson H, Negrini B, Janerich D. Hypertension, pregnancy, and risk of breast cancer. J Natl Cancer Inst 1989;81:1571-4.
8. Troisi R, Weiss H, Hoover RN, Potischman N, Swanson CA, Brogan DR, et al. Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 1998;9:641-7.
9. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6.
10. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995;11:198-200.
11. Pridjan G, Puschett JB. Preeclampsia. Part 2: experimental and genetic considerations. Obstet Gynecol Surv 2002;57:619-40.
12. Sherer DM, Abulafia O. Angiogenesis during implantation and placental and early embryonic development. Placenta 2001;22:1-13.
13. Odegard RA, Vatten LJ, Tore Nielsen S, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. Br J Obstet Gynaecol 2000;107:1410-6.
14. Zusterzeel P, Peters W, Visser W, Hermsen K, Roelofs H, Steegers E. A polymorphism in the gene for microsomal epoxide hydrolase is associated with preeclampsia. J Med Genet 2001;38:234-7.
15. Zhao H, Spitz MR, Gwyn KM, Wu X. Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Mol Carcinog 2002;33:99-104.
16. Park JY, Schantz SP, Lazarus P. Epoxide hydrolase genotype and orolaryngeal cancer risk: interaction with GSTM1 genotype. Oral Oncol 2003;39:483-90.
17. Chikosi AB, Moodley J, Pegoraro RJ, Lanning PA, Rom L. 5,10 methylenetetrahydrofolate reductase polymorphism in black South African women with pre-eclampsia. Br J Obstet Gynaecol 1999;106:1219-20.